Jump to content

Talk:David A. Sinclair

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
(Redirected from Talk:David Andrew Sinclair)

Pretty lush

[edit]

I don't know why, but I get the feeling that a friend of this person wrote the article. Or at least a fan. It reads like a eulogy, which is ironic because so much of his research has to do with avoiding that sort of thing. Maybe resume is a better analogy. Anyhow, I'm putting up a resume-style template message. Rhetth (talk) 03:29, 5 January 2009 (UTC)[reply]

lush alright and it's been edited by a wikipedian named davidasinclair and another one named editorboxofnumbers that know a whole lot about davidasinclair Havadmed (talk) 03:29, 16 April 2024 (UTC)[reply]
Any critique of his work can absolutely be included so long as it is in WP:RS. In fact, use of secondary independent sources is expected, rather than citing David's own primary source work. Zenomonoz (talk) 03:58, 16 April 2024 (UTC)[reply]

Mail

[edit]

Hi from Germany Von: "Sinclair, David Andrew" <david_sinclair@hms.harvard.edu> An: "alia@... Datum: 22.12.2013 00:25 Hi Alia, Im David SInclair, age 44, born sydney Australia. Here is my CV. School was St. Ives High School, Sydney. Married, 3 children. Thanks, David --Alia 2005 (talk) 01:30, 22 December 2013 (UTC)[reply]

new Mail:

Von: "Sinclair, David Andrew" <david_sinclair@hms.harvard.edu> An: "alia@..." Datum: 22.12.2013 13:03 1969, June 26th. Danke --Alia 2005 (talk) 13:04, 24 December 2013 (UTC)[reply]

Professor

[edit]

New Mail Von: "Sinclair, David Andrew" <david_sinclair@hms.harvard.edu> An: "alia@..." Datum: 25.12.2013 01:29 Thank you Alia! I obtained Bachelor of Science (BSc) with First Class honors at the University of New South Wales (UNSW), Sydney, Australia. Ph.D. in Biochemistry and Molecular genetics. Ph.D. = Doctor of Philosophy Yes I am a tenured professor in the Genetics Depertment of Harvard Medical School (HMS), Boston, Massachusetts Im also a co-joint Professor at the University of New South Wales (UNSW), Sydney, Australia. David Sinclair is a scientist and entrepreneur working on increasing human health, productivity, and lifespan. After co-discovering a molecular cause of aging at the Massachusetts Institute in Boston in the mid-1990s in the Laboratory of Leonard Guarente, he joined the faculty of Harvard Medical School at the age of 29 as one of their youngest faculty members, where is now a full tenured professor in the Genetics Department. In 2005, he founded the Glenn Laboratories for Aging Research and serves as their Co-Director. He co-founded the Journal Aging in 2009. He is also a Professor at the Lowy Cancer Center at the University of New South Wales in the Department of Pharmacology. His main line of research is aimed at understanding why we grow old and on using this knowledge to prevent and treat both rare and common diseases. His is perhaps best known for identifying resveratrol from red wine as an anti-aging molecule. He has founded five biotechnology companies to treat diseases (Sirtris, NASDAQ: SIRT), improve female reproductive health and IVF (OvaScience, NASDAQ: OVAS), treat type 2 diabetes (Cohbar), to develop vaccines against malaria, chlamydia, tuberculosis, pneumonia, and cancer (Genocea), and to reverse aging and age-related diseases (MetroBiotech). He spoke at TEDx and TEDMED events in 2008 and 2012. He has received numerous awards including The Australian Commonwealth Prize, the Nathan Shock Award and a MERIT Awards from the National Institutes of Health, the Merck Prize, the Genzyme Outstanding Achievement in Biomedical Science Award, the Bio-Innovator award, and Cosmos’ magazine's Bright Sparks award for Top Scientists under 40. He is featured in numerous books including "The Yough Pill" by David Stipp and "Immortal Quest" by Leonard Guarente. A fictional story was written about his research and Merry Xmas, David --Alia 2005 (talk) 04:38, 25 December 2013 (UTC)[reply]

Sirtris update

[edit]

The history of Sirtris ends with the acquisition by GlaxoSmithKline in 2008. It should be mentioned that GSK shut down Sirtris in 2013. http://www.xconomy.com/boston/2013/03/12/glaxosmithkline-shuts-down-sirtris-five-years-after-720m-buyout — Preceding unsigned comment added by 37.210.161.59 (talk) 19:08, 8 January 2017 (UTC)[reply]

Sinclair article is Terribly inadequate considering importance / public interest

[edit]

It's more scrubbed for politeness than informative, much less controversial, good or bad. Is this because of a trend away from text generally? To my mind Wikipedia 'must' stand up as an authoritative source. Anyway, I can list some topics I'd like to see covered (IF I can get around this HORRIBLE ARCHAIC EDITOR):

  • Dr. Sinclair as showman
  • Rightful successor to Durk and Sandy's ideas?
  • How have Sinclairs ideas and claims aged?
  • What are other luminaries past and present saying about Sinclair?

--Xgenei (talk) 02:02, 20 September 2020 (UTC)[reply]

Reason for change to short description (Australian biogerontologist --> Australian geneticist)

[edit]

There are no notable sources that I could find that call Sinclair a biogerontologist. However, there are reliable sources such as [1][2][3][4] that refer to him as a geneticist. Also, he is a professor of genetics. While Sinclair is a biogerontologist, his work focuses more on the genetic aspects of aging; biogerontology includes more than just genetics. Therefore, it would be more fitting to describe him as a geneticist. Ajshul 😃 (talk) 13:29, 23 March 2021 (UTC)[reply]

Requested move 23 March 2021

[edit]
The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.

The result of the move request was: moved. (non-admin closure) ~ Aseleste (t, e | c, l) 15:58, 30 March 2021 (UTC)[reply]



David Andrew SinclairDavid A. Sinclair – In almost all sources, David Sinclair or David A. Sinclair is used to refer to the subject, never David Andrew Sinclair (See [5] [6] [7] and also his name as the author of his book). Currently, there is a redirect at David A. Sinclair, which originally redirected to this subject's page, but then changed to a redirect to a disambiguation page with two David A. Sinclair's, one of them being this subject, and the other being a subject with no article anymore. With only this David A. Sinclair currently on Wikipedia, and with David Andrew Sinclair never really being used to refer to the subject in any sources, per WP:NCBIO and more specifically, per WP:INITS, this page should be moved there. Ajshul 😃 (talk) 15:09, 23 March 2021 (UTC) Ajshul 😃 (talk) 15:22, 23 March 2021 (UTC)[reply]

The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.

Accusations of Grifting and Fraud

[edit]

Numerous attempts to reproduce Sinclair’s studies have revealed problems with his claims, and his business practices show that Sinclair has profited from these sketchy studies. 2600:8806:A624:5D00:1CD2:8338:98E6:24AD (talk) 22:20, 26 August 2024 (UTC)[reply]

Edit request

[edit]

I am a colleague of David Sinclair and believe I would have a conflict of interest when editing his article. I would therefore like to make these requests on the talk page to update the current status of the article.  

The paragraph at the end of the career section states the following:

In 2024, Sinclair and his brother Nicholas Sinclair announced that their company Animal Bioscience had proven that a supplement for dogs with nondisclosed ingredients reversed aging. This claim met with widely expressed outrage in the research community. The controversy resulted in a wave of resignations from The Academy for Health and Lifespan Research, a group of scientists that Sinclair had co-founded, and Sinclair resigned as The Academy's President in March 2024.

The references used do not say “widely expressed outrage.” The Wall Street Journal also says that four people resigned, not a “wave of resignations.” I would request the paragraph be changed to the following:

In 2024, Sinclair resigned as the president of The Academy for Health and Lifespan Research, an organization he had previously co-founded. The resignation came after four resignations within the organization and outrage that was sparked from Sinclair’s announcement that Animal Bioscience had proven that a supplement for dogs with nondisclosed ingredients  reversed aging. Staringatme (talk) 21:18, 21 October 2024 (UTC)[reply]

I have done some minor tidy up. I don't think it had the major issues you argue, but I've attributed to WSJ. As a WP:RS, it does use the word "outrage". Zenomonoz (talk) 21:40, 21 October 2024 (UTC)[reply]